Articles tagged with “adhd-medication”

CTx-1301 Dexmethylphenidate: FDA Review & ADHD Clinical Data

Explore the clinical data and 505(b)(2) FDA regulatory pathway for CTx-1301 (dexmethylphenidate), a novel once-daily stimulant candidate for ADHD treatment.

40 min read

5/14/2026

ctx-1301 dexmethylphenidate adhd medication 505(b)(2) pathway pdufa stimulant therapy precision timed release fda approval